Black Diamond Therapeutics, Inc. Income Statement

Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.00M
Gross Profit -0.00M
Operating items
Research & Development 6.95M21.75M48.21M96.83M
Selling, General & Administrative 1.95M7.58M21.36M30.04M
Operating Expenses 8.90M29.33M69.57M126.87M
Operating Income -8.90M-29.33M-69.57M-126.87M
EBIT -8.90M-29.33M-69.57M-126.87M
Non-operating items
Interest & Investment Income 0.00M0.46M4.04M3.46M
Other Non Operating Income -0.02M-6.39M-1.72M-2.19M
Non Operating Income -0.03M-5.93M2.32M-2.19M
Net income details
EBT -8.90M-28.87M-65.53M-123.41M
Profit After Tax -8.93M-35.26M-67.25M-125.60M
Income from Continuing Operations -8.90M-28.87M-65.53M-123.41M
Consolidated Net Income -8.90M-28.87M-65.53M-123.41M
Income towards Parent Company -8.90M-28.87M-65.53M-123.41M
Net Income towards Common Stockholders -8.90M-28.87M-65.53M-123.41M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M
Shares Outstanding (Weighted Average) 32.64M36.00M36.23M36.37M51.64M56.59M
Shares Outstanding (Diluted Average) 32.91M
EBITDA -8.90M-35.26M-66.64M-126.62M